Xlife Sciences AG

Fr 8.42As of Sun 8 Nov 2026, 12:00 UTC
SWX:XLSHealthcare
Country Switzerland
PE (Fwd) •••
TSR 5Y CAGR (30.03%)
Div yield —
ROE (64.12%)
Biotechnology
Beta (5Y) 0.51
PE TTM —
TSR TTM (56.82%)
Mkt cap Fr 48.56M
ROIC (11.94%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
Fr 10
23.65%
5.70%
Hold 7|12|1|5|1
4Q25
1Q26
2Q26
3Q26
Earnings per shareFr
0.08
0.09
0.10
0.10
3.71%
5.07%
19.03%
18.63%
RevenueFr M
3.210
3.298
3.292
3.361
5.53%
10.04%
11.53%
7.54%
Peers (US$59.55M)
Cap (US$)
PE
161.1M
—
Capital
TTM
5Y
10Y
Leveragex
4.706
1.074
0.887
EBIT/Intx
1.582
0.402
0.366
Own earn%
222.51
(8.13)
21.63
Sh yield%
22.56
37.36
34.92
Owners
Insiders/Inst%
6.76
75.13
Short interest%
2.51
SBC / revenue%
4.46
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
19–26
$1 testx
0.1
Incr. ROIC%
4